Towards personalized therapy for multiple sclerosis: limitations of observational data

Affiliations

¹ Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
² Division of Cardiovascular Medicine, Harvard Medical School, Boston, MA, USA.

Comment

Ewout W Steyerberg et al. Brain. 2018.

. 2018 May 1;141(5):e38.

doi: 10.1093/brain/awy055.

¹ Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.
² Division of Cardiovascular Medicine, Harvard Medical School, Boston, MA, USA.

No abstract available

Comment in

Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data.
Kalincik T. Kalincik T. Brain. 2018 May 1;141(5):e39. doi: 10.1093/brain/awy056. Brain. 2018. PMID: 29514191 No abstract available.

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.
Kalincik T, Manouchehrinia A, Sobisek L, Jokubaitis V, Spelman T, Horakova D, Havrdova E, Trojano M, Izquierdo G, Lugaresi A, Girard M, Prat A, Duquette P, Grammond P, Sola P, Hupperts R, Grand'Maison F, Pucci E, Boz C, Alroughani R, Van Pesch V, Lechner-Scott J, Terzi M, Bergamaschi R, Iuliano G, Granella F, Spitaleri D, Shaygannejad V, Oreja-Guevara C, Slee M, Ampapa R, Verheul F, McCombe P, Olascoaga J, Amato MP, Vucic S, Hodgkinson S, Ramo-Tello C, Flechter S, Cristiano E, Rozsa C, Moore F, Luis Sanchez-Menoyo J, Laura Saladino M, Barnett M, Hillert J, Butzkueven H; MSBase Study Group. Kalincik T, et al. Brain. 2017 Sep 1;140(9):2426-2443. doi: 10.1093/brain/awx185. Brain. 2017. PMID: 29050389 Clinical Trial.